Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821924 · ClinicalTrials.gov registry record
Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 2,347
- Enrollment target
NCT01821924 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,347 participants.
The verdict
NCT01821924 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 2,347 participants
- Enrollment target
Study Summary
The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators are interested in how these MRI findings relate to long-term prognosis in people who are at risk for cardiac disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,347 participants |
| Start Date | 2012-01-30 |
| Est. Completion | 2018-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01821924
The ClinicalTrials.gov registry entry for NCT01821924 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,347 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01821924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01821924 about?
NCT01821924 is a clinical study titled "Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD". The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators are interested in how these MRI findings relate to long-term prognosis in people who are at risk for...
What is the current status of trial NCT01821924?
This trial is currently completed. The enrollment target is 2,347 participants. The study started on 2012-01-30. Estimated completion is 2018-08-30.
Who is sponsoring clinical trial NCT01821924?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.